Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults

Vascular Aging Clinical Trial

Official title:
Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults

Status Completed

Clinical Trial Summary

The proposed study will assess the ability of a naturally occurring sugar to improve the function of arteries with age. Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk of cardiovascular disease with age.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Vascular Aging

Clinical Trial Details

NCT number	NCT01575288
Study type	Interventional
Source	University of Colorado, Boulder
Contact
Status	Completed
Phase	N/A
Start date	May 2012
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04413994` - Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)	N/A
Completed	`NCT02022670` - Sodium Nitrite to Treat Arterial Aging	Phase 1/Phase 2
Active, not recruiting	`NCT01968564` - Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function	N/A
Completed	`NCT02795624` - Vascular Aging in Flight Attendants With Occupational Secondhand Smoke Exposure
Recruiting	`NCT05296395` - Vascular Aging and Lp299v Study	N/A